Thompson JF - Search Results

1

Is melphalan dose adjustment according to ideal body weight useful in isolated limb infusion for melanoma?

Huismans AM, Kroon HM, Haydu LE, Kam PC, Thompson JF. Huismans AM, et al. Among authors: thompson jf. Ann Surg Oncol. 2012 Sep;19(9):3050-6. doi: 10.1245/s10434-012-2316-4. Epub 2012 Apr 24. Ann Surg Oncol. 2012. PMID: 22526898

2

Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma.

Lindnér P, Doubrovsky A, Kam PC, Thompson JF. Lindnér P, et al. Among authors: thompson jf. Ann Surg Oncol. 2002 Mar;9(2):127-36. doi: 10.1007/BF02557363. Ann Surg Oncol. 2002. PMID: 11888868

3

Is there a role for isolated limb perfusion with tumor necrosis factor in patients with melanoma?

De Wilt JH, Thompson JF. De Wilt JH, et al. Among authors: thompson jf. Ann Surg Oncol. 2004 Feb;11(2):119-21. doi: 10.1245/aso.2004.12.932. Ann Surg Oncol. 2004. PMID: 14761911 No abstract available.

4

The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.

Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ. Francken AB, et al. Among authors: thompson jf. Ann Surg Oncol. 2004 Apr;11(4):426-33. doi: 10.1245/ASO.2004.07.014. Epub 2004 Mar 15. Ann Surg Oncol. 2004. PMID: 15070604

5

Pathology of melanocytic lesions: new, controversial, and clinically important issues.

Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW. Scolyer RA, et al. Among authors: thompson jf. J Surg Oncol. 2004 Jul 1;86(4):200-11. doi: 10.1002/jso.20083. J Surg Oncol. 2004. PMID: 15221927 Review.

6

The history and future of melanoma staging.

Thompson JF, Shaw HM, Hersey P, Scolyer RA. Thompson JF, et al. J Surg Oncol. 2004 Jul 1;86(4):224-35. doi: 10.1002/jso.20082. J Surg Oncol. 2004. PMID: 15221929 Review.

7

Isolated limb infusion for melanoma: a simple but effective alternative to isolated limb perfusion.

Thompson JF, Kam PC. Thompson JF, et al. J Surg Oncol. 2004 Oct 1;88(1):1-3. doi: 10.1002/jso.20112. J Surg Oncol. 2004. PMID: 15384062 Review. No abstract available.

8

Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma.

Starritt EC, Uren RF, Scolyer RA, Quinn MJ, Thompson JF. Starritt EC, et al. Among authors: thompson jf. Ann Surg Oncol. 2005 Jan;12(1):18-23. doi: 10.1007/s10434-004-1163-3. Epub 2004 Dec 27. Ann Surg Oncol. 2005. PMID: 15827773 Clinical Trial.

9

Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy.

Yee VS, Thompson JF, McKinnon JG, Scolyer RA, Li LX, McCarthy WH, O'Brien CJ, Quinn MJ, Saw RP, Shannon KF, Stretch JR, Uren RF. Yee VS, et al. Among authors: thompson jf. Ann Surg Oncol. 2005 Jun;12(6):429-39. doi: 10.1245/ASO.2005.03.074. Epub 2005 Apr 28. Ann Surg Oncol. 2005. PMID: 15886905

10

A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma.

van Poll D, Thompson JF, Colman MH, McKinnon JG, Saw RP, Stretch JR, Scolyer RA, Uren RF. van Poll D, et al. Among authors: thompson jf. Ann Surg Oncol. 2005 Aug;12(8):597-608. doi: 10.1245/ASO.2005.08.012. Epub 2005 Jun 16. Ann Surg Oncol. 2005. PMID: 16021534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,228 results

Search Page

Filters